Conversely, KDM4B inhibition in breast cancer cells induced resistance to TOP2 inhibitors doxorubicin and etoposide [10], whereas the ectopic expression of KDM4B sensitized cells to etoposide [34]. Here, KDM4B is linked to breast carcinoma.